JDonaldEastonMD

PubMed

• 2 citations
  Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial.
  Victor J Del Brutto, Han-Christoph Diener, J Donald Easton, Christopher B Granger, Lisa Cronin, Eva Kleine, Claudia Grauer, Martina Brueckmann, Kazunori Toyoda, Peter ...> ;Journal of the American Heart Association. 2022 Jun 7
• 19 citations
  Review and update of the concept of embolic stroke of undetermined source.
  Hans-Christoph Diener, J Donald Easton, Robert G Hart, Scott Kasner, Hooman Kamel, George Ntaios> ;Nature Reviews. Neurology. 2022 Aug 1
• 5 citations
  Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial.
  Sara K Rostanski, Alexandra Kvernland, Ava L Liberman, Adam de Havenon, Nils Henninger, Brian Mac Grory, Anthony S Kim, J Donald Easton, S Claiborne Johnston, Shadi Yaghi> ;JAMA Neurology. 2022 Mar 1
• 9 citations
  Antiplatelet Use and Ischemic Stroke Risk in Minor Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the POINT Trial
  Mohammad Anadani, Adam de Havenon, Nils Henninger, Lindsey Kuohn, Brian Mac Grory, Karen L. Furie, Anthony S. Kim, J. Donald Easton, S. Claiborne Johnston, Shadi Yaghi> ;Stroke. 2021 Oct 12
• 24 citations
  Predictors of Development of Atrial Fibrillation in Patients With Embolic Stroke Of Undetermined Source: An Analysis of the RE-SPECT ESUS Trial
  Maria Cecilia Bahit, Ralph L. Sacco, J. Donald Easton, Juliane Meyerhoff, Lisa Cronin, Eva Kleine, Claudia Grauer, Martina Brueckmann, Hans-Christoph Diener, Renato D....> ;Circulation. 2021 Sep 28
• 7 citations
  Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke T...
  Adam de Havenon, S. Claiborne Johnston, J. Donald Easton, Anthony S. Kim, Kevin N. Sheth, Maarten G Lansberg, David L. Tirschwell, Eva Mistry, Shadi Yaghi> ;JAMA Network Open. 2021 Jun 1
• 14 citations
  Carotid Stenosis and Recurrent Ischemic Stroke: A Post-Hoc Analysis of the POINT Trial.
  Shadi Yaghi, Adam de Havenon, Sara K. Rostanski, Alexandra Kvernland, Brian Mac Grory, Karen L. Furie, Anthony S. Kim, J. Donald Easton, S. Claiborne Johnston, Nils He...> ;Stroke. 2021 May 4
• 2 citations
  Newly Diagnosed Atrial Fibrillation After Transient Ischemic Attack Versus Minor Ischemic Stroke in the POINT Trial.
  Hooman Kamel, Mary Farrant, J. Donald Easton, Luciano A. Sposato, Jordan J. Elm, Ellen Underwood, S. Claiborne Johnston> ;Journal of the American Heart Association. 2021 Mar 16
• 3 citations
  Dabigatran or Aspirin in East Asian Patients With Embolic Stroke of Undetermined Source: RE-SPECT ESUS Subgroup Analysis.
  Shinichiro Uchiyama, Kazunori Toyoda, Byung-Chul Lee, Chia-Wei Liou, Lawrence Ka Sing Wong, Claudia Grauer, Martina Brueckmann, Atsushi Taniguchi, Yasuhisa Urano, J. D...> ;Stroke. 2021 Feb 16
• 17 citations
  Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS.
  Hans-Christoph Diener, Aurauma Chutinet, J. Donald Easton, Christopher B. Granger, Eva Kleine, Lars Marquardt, Juliane Meyerhoff, Andrea Zini, Ralph L. Sacco> ;Stroke. 2021 Jan 28
• 19 citations
  Non-vitamin K oral anticoagulants for secondary stroke prevention in patients with atrial fibrillation.
  Hans-Christoph Diener, Graeme J. Hankey, J. Donald Easton, Gregory Y.H. Lip, Robert G. Hart, Valeria Caso> ;European Heart Journal Supplements. 2020 Sep 1
• 8 citations
  Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.
  Scott R. Evans, Mikael Knutsson, Pierre Amarenco, Gregory W. Albers, Philip M.W. Bath, Hans Denison, Per Ladenvall, Jenny Jonasson, J. Donald Easton, Kazuo Minematsu, ...> ;Clinical Trials. 2020 Jul 15
• 17 citations
  Efficacy of Clopidogrel for Prevention of Stroke Based on CYP2C19 Allele Status in the POINT Trial
  James F. Meschia, Ronald L. Walton, Luca P. Farrugia, Owen A. Ross, Jordan J. Elm, Mary Farrant, William J. Meurer, Anne S. Lindblad, William G. Barsan, Marilou Ching,...> ;Stroke. 2020 Jun 17
• 20 citations
  Antithrombotic Treatment of Embolic Stroke of Undetermined Source: RE-SPECT ESUS Elderly and Renally Impaired Subgroups.
  Hans-Christoph Diener, Ralph L. Sacco, J. Donald Easton, Christopher B. Granger, Michal Bar, Richard A. Bernstein, Michael Brainin, Martina Brueckmann, Lisa Cronin, Ge...> ;Stroke. 2020 May 14
• 22 citations
  Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial.
  Brett Cucchiara, Jordan J. Elm, J. Donald Easton, Shelagh B. Coutts, Joshua Z. Willey, Michelle H. Biros, Michael A. Ross, S. Claiborne Johnston> ;Stroke. 2020 Feb 12
• 117 citations
  Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Di...
  Yuesong Pan, Jordan J. Elm, Hao Li, J. Donald Easton, Yilong Wang, Mary Farrant, Xia Meng, Anthony S. Kim, Xingquan Zhao, William J. Meurer, Liping Liu, Dennis Dietric...> ;JAMA Neurology. 2019 Dec 1
• 10 citations
  Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Ana...
  Mary Farrant, J. Donald Easton, Eric E. Adelman, Brett Cucchiara, William G. Barsan, Holly Tillman, Jordan J. Elm, Anthony S. Kim, Anne S. Lindblad, Yuko Y. Palesch, W...> ;JAMA Network Open. 2019 Sep 4
• 30 citations
  Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Second...
  Holly Tillman, S. Claiborne Johnston, Mary Farrant, William G. Barsan, Jordan J. Elm, Anthony S. Kim, Anne S. Lindblad, Yuko Y. Palesch, J. Donald Easton> ;JAMA Neurology. 2019 Jul 1
• 42 citations
  Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke.
  S. Claiborne Johnston, Jordan J. Elm, J. Donald Easton, Mary Farrant, William G. Barsan, Anthony S. Kim, Anne S. Lindblad, Yuko Y. Palesch, Karla G. Zurita, Gregory W....> ;Circulation. 2019 Aug 20
• 87 citations
  Dual antiplatelet therapy using cilostazol for secondary prevention in patients with high-risk ischaemic stroke in Japan: a multicentre, open-label, randomised control...
  Kazunori Toyoda, Shinichiro Uchiyama, Takenori Yamaguchi, J. Donald Easton, Kazumi Kimura, Haruhiko Hoshino, Nobuyuki Sakai, Yasushi Okada, Kortaro Tanaka, Hideki Orig...> ;The Lancet. Neurology. 2019 Jun 1
• 426 citations
  Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source
  Hans-Christoph Diener, Ralph L. Sacco, J. Donald Easton, Christopher B. Granger, Richard A. Bernstein, Shinichiro Uchiyama, Jörg Kreuzer, Lisa Cronin, Daniel Cotton, C...> ;The New England Journal of Medicine. 2019 May 15
• 6 citations
  Estimated treatment effect of ticagrelor versus aspirin by investigator-assessed events compared with judgement by an independent event adjudication committee in the S...
  J. Donald Easton, Hans Denison, Scott R. Evans, Mikael Knutsson, Pierre Amarenco, Gregory W. Albers, Per Ladenvall, Kazuo Minematsu, Carlos A. Molina, Yongjun Wang, Ks...> ;International Journal of Stroke. 2019 May 15
• 3 citations
  Time to Loading Dose and Risk of Recurrent Events in the SOCRATES Trial
  Carlos A. Molina, S. Claiborne Johnston, Per Ladenvall, Pierre Amarenco, Gregory W. Albers, Hans Denison, J. Donald Easton, Scott R. Evans, Peter Held, Mikael Knutsson...> ;Stroke. 2019 Mar 1
• 4 citations
  New opportunities to optimize antithrombotic therapy for secondary stroke prevention.
  Anthony S. Kim, J. Donald Easton> ;International Journal of Stroke. 2019 Feb 6
• 13 citations
  Non-vitamin-K oral anticoagulants (NOACs) for the prevention of secondary stroke.
  Hans-Christoph Diener, George Ntaios, Martin O'Donnell, J. Donald Easton> ;Expert Opinion on Pharmacotherapy. 2018 Sep 17
• Join now to see all